after 30 days of treatment = t1

4 trials

Sponsors

National Inter-university Consortium of Research in Innovative Pharmaceutical Technologies - Tefarco Innova, Epo S.r.l., Istituto Nazionale Biostrutture e Biosistemi

Conditions

Functional dyspepsia Digestive SystemImpaired fasting plasma glucose (fasting plasma glucose between 90 and 120 mg/dL) Nutritional, Metabolic, EndocrineMild hypercholesterolemia Nutritional, Metabolic, EndocrinePreventing periodontitis in individuals with symptomatic gingivitis Oral Health

Unknown Phase

The beneficial effect of ingestion of a food supplement based on a pool of digestive enzymes in people with functional dyspepsia

Active, not recruitingISRCTN67691215

Istituto Nazionale Biostrutture e BiosistemiFunctional dyspepsia Digestive System

Start: 2023-06-16Target: 120Updated: 2023-12-12

The beneficial effect on gingivitis of a food supplement based on botanical extracts

Active, not recruitingISRCTN16727861

Epo S.r.l.Preventing periodontitis in individuals with symptomatic gingivitis Oral Health

Start: 2023-07-07Target: 60Updated: 2024-04-08

The beneficial effect on cardiovascular function of a food supplement based on red yeast rice (monacolin K), gamma-oryzanol from rice bran, and gamma-aminobutyric acid.

Active, not recruitingISRCTN90678255

Istituto Nazionale Biostrutture e BiosistemiMild hypercholesterolemia Nutritional, Metabolic, Endocrine

Start: 2023-09-21Target: 88Updated: 2024-09-23

The beneficial effect on sugar metabolism of a food supplement based on plant extracts, zinc and chromium

Active, not recruitingISRCTN15697400

National Inter-university Consortium of Research in Innovative Pharmaceutical Technologies - Tefarco InnovaImpaired fasting plasma glucose (fasting plasma glucose between 90 and 120 mg/dL) Nutritional, Metabolic, Endocrine

Start: 2021-05-13Target: 81Updated: 2026-03-16